by Alwin L | Nov 10, 2025 | Mass Tort Settlements
The Depo-Provera multidistrict litigation (MDL) has quickly become one of the most closely watched pharmaceutical mass actions of the decade. Plaintiffs from across the United States have alleged that the popular contraceptive injection—manufactured by Pfizer—caused...
by Olivia Pollock | Oct 20, 2025 | Lien Resolution Processes
A government shutdown has wide-ranging implications for Americans, and one of the most critical concerns is how it disrupts Medicare—the insurance lifeline for over 60 million seniors and people with disabilities. In October 2025, the U.S. government shut down due to...
by Olivia Pollock | Oct 6, 2025 | Medicare Compliance
When it comes to lien resolution and settlement compliance, accurate Medicare reporting is not just a technicality—it’s the backbone of protecting clients, law firms, and insurance entities from costly consequences. Major regulatory changes slated for enforcement in...
by Olivia Pollock | Sep 29, 2025 | MMSEA Defense Reporting
The Medicare, Medicaid, and SCHIP Extension Act of 2007 (MMSEA) Section 111 requires RREs—liability insurers, no-fault insurers, workers’ compensation insurers, and self-insureds—to report settlement, judgment, award, or other payment obligations to Medicare...
by Olivia Pollock | Sep 15, 2025 | Mass Tort Settlements
TDF, or tenofovir disoproxil fumarate, is a compound found in leading HIV drugs like Truvada, Viread, Atripla, Complera, and Stribild. Over the past several years, TDF litigation has taken center stage in the pharmaceutical industry, as thousands of plaintiffs have...
